STERIS plc (STE)
Healthcare · end-of-day data as of Oct 16, 2026
The average 12-month analyst price target for STE is $276.53, 24.2% above the last close of $222.66 on Oct 16, 2026; targets range from $267.71 to $289.15. Rating consensus: Buy.
Snapshot
- P/E27.2x
- P/E vs sector-3.3%
- P/E vs own-12.6%
- Target upside+24.2%
- ConsensusBuy
- Market cap$21.71B
- FCF yield+4.3%
- Insiders-$957K
- Earnings in19d
- News
Why it moved
STERIS plc (STE) fell 0.7% on Oct 16, 2026.
The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move came from the market as a whole.
1 story on the day (30-day average 1.9).
Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.
Price and events
Last close $222.66 · -6.3% over 1y · E earnings · D dividend · S split · A analyst rating change
Technicals
- Trendsideways
- Sector▲ +16.0%
- MAs20▲ 50▲ 100▲ 200▼
- Above MAs3 of 4 above
- MA20×50↑ in ~12d
- RSI62
- Support-1.7%
- Resistance+3.2%
- Off 52w high-16.4%
- Off ATH-16.4%
- 52w range$222.66
- Bollingerabove upper
- MACD2.11
- ATR+2.2%
- Volume1.0x
Analyst price targets
3 firms with a target in the last 12 months · last close $222.66 · as of Oct 16, 2026
Strong buy 3 · Buy 4 · Hold 2 · Sell 0 · Strong sell 0
Revenue and free cash flow
Q1 FY2027: Revenue +7.3% year over year, free cash flow 18.7% of revenue, operating margin 19.1%.
| Q1 FY2027 | Jun 30, 2026 | $1.49B | 2.04 | $280M | 45.8% | 19.1% | 13.4% |
| Q4 FY2026 | Mar 31, 2026 | $1.59B | 2.24 | $245M | 43.9% | 19.9% | 13.9% |
| Q3 FY2026 | Dec 31, 2025 | $1.5B | 1.96 | $200M | 43.8% | 18.1% | 12.9% |
| Q2 FY2026 | Sep 30, 2025 | $1.46B | 1.94 | $201M | 44.2% | 18.4% | 13.1% |
| Q1 FY2026 | Jun 30, 2025 | $1.39B | 1.79 | $326M | 45.1% | 17.7% | 12.8% |
| Q4 FY2025 | Mar 31, 2025 | $1.48B | 1.48 | $190M | 43.3% | 14.6% | 9.8% |
| Q3 FY2025 | Dec 31, 2024 | $1.37B | 1.75 | $244M | 44.5% | 17.9% | 12.7% |
| Q2 FY2025 | Sep 30, 2024 | $1.33B | 1.51 | $149M | 43.6% | 16.5% | 11.3% |
Peers
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 | $384.02 | +0.3% | 0.0% | +1.9% | 49.1 | $27.03B | ||
| 2 | $235.00 | -1.7% | -4.7% | -0.5% | 24.9 | $25.94B | ||
| 3 | $317.95 | -2.2% | -6.1% | +5.8% | 26.3 | $25.79B | ||
| 4 | $113.07 | -0.2% | -13.0% | +13.6% | 14.4 | $22.92B | ||
| 5 | $222.66 | -0.7% | -16.4% | +24.2% | 27.2 | $21.71B | ||
| 6 | $18.66 | +2.4% | 0.0% | +9.8% | — | $21.43B | ||
| 7 | $94.98 | +0.6% | -7.7% | +9.0% | 23.1 | $18.12B | ||
| 8 | $152.64 | -1.3% | -3.0% | -18.2% | 72.7 | $17.03B |
Data as of Oct 16, 2026 close.
Latest news
Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.